168 related articles for article (PubMed ID: 16373603)
1. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.
Kardys I; Oei HH; van der Meer IM; Hofman A; Breteler MM; Witteman JC
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):631-6. PubMed ID: 16373603
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
Koenig W; Twardella D; Brenner H; Rothenbacher D
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
10. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A2 is associated with risk of dementia.
van Oijen M; van der Meer IM; Hofman A; Witteman JC; Koudstaal PJ; Breteler MM
Ann Neurol; 2006 Jan; 59(1):139-44. PubMed ID: 16278861
[TBL] [Abstract][Full Text] [Related]
14. Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index.
Santos S; Rooke TW; Bailey KR; McConnell JP; Kullo IJ
Vasc Med; 2004 May; 9(3):171-6. PubMed ID: 15675180
[TBL] [Abstract][Full Text] [Related]
15. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.
Sudhir K
J Clin Endocrinol Metab; 2005 May; 90(5):3100-5. PubMed ID: 15713711
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.
Gerber Y; McConnell JP; Jaffe AS; Weston SA; Killian JM; Roger VL
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2517-22. PubMed ID: 16902161
[TBL] [Abstract][Full Text] [Related]
17. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
18. The effect of statin therapy on lipoprotein associated phospholipase A2 levels.
Albert MA; Glynn RJ; Wolfert RL; Ridker PM
Atherosclerosis; 2005 Sep; 182(1):193-8. PubMed ID: 15982658
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
[TBL] [Abstract][Full Text] [Related]
20. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.
Liu H; Yao Y; Wang Y; Ji L; Zhu K; Hu H; Chen J; Yang J; Cui Q; Geng B; Liu Q; Li D; Zhou Y
J Cell Mol Med; 2018 Oct; 22(10):5145-5150. PubMed ID: 30094934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
